Zhejiang Medicine Co.,Ltd.’s Net Profit Dropped 13.1% in First Quarter of 2022

Zhejiang Medicine Co.,Ltd. (浙江医药股份有限公司) (600216.SH) reported a net profit of 214.8 million yuan in the first quarter of 2022, down 13.1% year-on-year.

Meanwhile, the company posted 2.2 billion yuan in revenue, down 9% year-on-year.

At the end of the reporting period, it had 12.6 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 25.3%.